TMEM176A
gene geneOn this page
Also known as HCA112MS4B1
Summary
TMEM176A (transmembrane protein 176A, HGNC:24930) is a protein-coding gene on chromosome 7q36.1, encoding Transmembrane protein 176A (Q96HP8).
Predicted to act upstream of or within negative regulation of dendritic cell differentiation. Predicted to be located in membrane.
Source: NCBI Gene 55365 — RefSeq curated summary.
At a glance
- GWAS associations: 9
- Clinical variants (ClinVar): 47 total
- MANE Select transcript:
NM_018487
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:24930 |
| Approved symbol | TMEM176A |
| Name | transmembrane protein 176A |
| Location | 7q36.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | HCA112, MS4B1 |
| Ensembl gene | ENSG00000002933 |
| Ensembl biotype | protein_coding |
| OMIM | 610334 |
| Entrez | 55365 |
Gene structure
Transcript identifiers
Ensembl transcripts: 49 — 43 protein_coding, 6 retained_intron
ENST00000004103, ENST00000461345, ENST00000462826, ENST00000468689, ENST00000474166, ENST00000475007, ENST00000475536, ENST00000475710, ENST00000481305, ENST00000484928, ENST00000494349, ENST00000855157, ENST00000855158, ENST00000855159, ENST00000855160, ENST00000855161, ENST00000855162, ENST00000855163, ENST00000855164, ENST00000855165, ENST00000855166, ENST00000855167, ENST00000855168, ENST00000855169, ENST00000855170, ENST00000855171, ENST00000855172, ENST00000855173, ENST00000855174, ENST00000855175, ENST00000855176, ENST00000855177, ENST00000855178, ENST00000855179, ENST00000855180, ENST00000855181, ENST00000855182, ENST00000855183, ENST00000855184, ENST00000855185, ENST00000855186, ENST00000956676, ENST00000956677, ENST00000956678, ENST00000956679, ENST00000956680, ENST00000956681, ENST00000956682, ENST00000956683
RefSeq mRNA: 1 — MANE Select: NM_018487
NM_018487
CCDS: CCDS5909
Canonical transcript exons
ENST00000004103 — 7 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000729869 | 150801536 | 150801724 |
| ENSE00001827596 | 150800769 | 150800828 |
| ENSE00003493198 | 150803620 | 150803832 |
| ENSE00003604647 | 150804362 | 150804472 |
| ENSE00003656853 | 150803400 | 150803456 |
| ENSE00003674137 | 150802215 | 150802325 |
| ENSE00003832811 | 150804827 | 150805118 |
Expression profiles
Bgee: expression breadth ubiquitous, 259 present calls, max score 99.67.
FANTOM5 (CAGE): breadth broad, TPM avg 21.4836 / max 1351.2671, expressed in 641 samples.
FANTOM5 promoters (15 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 81977 | 16.2701 | 606 |
| 81974 | 1.3934 | 326 |
| 81973 | 0.9277 | 270 |
| 81980 | 0.7865 | 166 |
| 81972 | 0.6019 | 245 |
| 81979 | 0.2944 | 108 |
| 81983 | 0.2905 | 22 |
| 81985 | 0.2645 | 112 |
| 81978 | 0.2174 | 70 |
| 81975 | 0.1517 | 82 |
Top tissues by expression
281 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| right lobe of liver | UBERON:0001114 | 99.67 | gold quality |
| liver | UBERON:0002107 | 99.42 | gold quality |
| ileal mucosa | UBERON:0000331 | 98.98 | gold quality |
| dorsal root ganglion | UBERON:0000044 | 98.90 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 98.89 | gold quality |
| adult mammalian kidney | UBERON:0000082 | 98.88 | gold quality |
| renal medulla | UBERON:0000362 | 98.80 | gold quality |
| gall bladder | UBERON:0002110 | 98.67 | gold quality |
| rectum | UBERON:0001052 | 98.53 | gold quality |
| pericardium | UBERON:0002407 | 98.48 | gold quality |
| caecum | UBERON:0001153 | 98.44 | gold quality |
| granulocyte | CL:0000094 | 98.33 | gold quality |
| small intestine Peyer’s patch | UBERON:0003454 | 98.27 | gold quality |
| vermiform appendix | UBERON:0001154 | 98.22 | gold quality |
| saphenous vein | UBERON:0007318 | 98.20 | gold quality |
| vena cava | UBERON:0004087 | 98.03 | gold quality |
| nephron tubule | UBERON:0001231 | 97.97 | gold quality |
| small intestine | UBERON:0002108 | 97.83 | gold quality |
| trigeminal ganglion | UBERON:0001675 | 97.82 | gold quality |
| pylorus | UBERON:0001166 | 97.77 | gold quality |
| metanephros cortex | UBERON:0010533 | 97.76 | gold quality |
| transverse colon | UBERON:0001157 | 97.70 | gold quality |
| left ovary | UBERON:0002119 | 97.70 | gold quality |
| cardia of stomach | UBERON:0001162 | 97.69 | gold quality |
| type B pancreatic cell | CL:0000169 | 97.53 | gold quality |
| islet of Langerhans | UBERON:0000006 | 97.49 | gold quality |
| kidney epithelium | UBERON:0004819 | 97.45 | gold quality |
| right ovary | UBERON:0002118 | 97.36 | gold quality |
| lymph node | UBERON:0000029 | 97.07 | gold quality |
| kidney | UBERON:0002113 | 96.70 | gold quality |
Single-cell (SCXA)
Detected in 21 experiment(s), a significant marker in 21.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-MTAB-9906 | yes | 1055.11 |
| E-MTAB-9154 | yes | 976.46 |
| E-GEOD-124472 | yes | 709.50 |
| E-CURD-55 | yes | 502.90 |
| E-HCAD-38 | yes | 471.42 |
| E-HCAD-56 | yes | 298.87 |
| E-HCAD-11 | yes | 59.41 |
| E-HCAD-31 | yes | 42.25 |
| E-HCAD-10 | yes | 34.90 |
| E-GEOD-81547 | yes | 31.64 |
| E-MTAB-5061 | yes | 30.38 |
| E-MTAB-10553 | yes | 29.74 |
| E-MTAB-8410 | yes | 24.22 |
| E-CURD-46 | yes | 23.84 |
| E-GEOD-135922 | yes | 23.14 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
14 targeting TMEM176A, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4795-3P | 100.00 | 74.62 | 4024 |
| HSA-MIR-4725-3P | 99.96 | 69.53 | 2520 |
| HSA-MIR-6780B-5P | 99.96 | 69.60 | 2562 |
| HSA-MIR-185-3P | 99.95 | 67.01 | 1743 |
| HSA-MIR-4778-3P | 99.93 | 70.40 | 1818 |
| HSA-MIR-4271 | 99.88 | 68.32 | 2244 |
| HSA-MIR-4530 | 99.69 | 66.47 | 1509 |
| HSA-MIR-1227-5P | 98.65 | 65.32 | 1549 |
| HSA-MIR-3135B | 98.61 | 65.33 | 1470 |
| HSA-MIR-510-5P | 97.66 | 65.82 | 916 |
| HSA-MIR-6762-5P | 96.55 | 64.62 | 972 |
| HSA-MIR-6845-5P | 96.55 | 64.65 | 969 |
| HSA-MIR-6782-5P | 96.45 | 64.42 | 612 |
| HSA-MIR-6747-5P | 96.17 | 64.99 | 743 |
Literature-anchored findings (GeneRIF, showing 8)
- human TMEM176A and 176B protein levels are significantly elevated in lymphoma, but not in normal tissues (PMID:22244448)
- Study characterized Tmem176a and b expression in RORgamma t+ lymphocytes at transcriptional and protein levels and present evidence that both genes exert a redundant ion channel function related to a colocalisation in close proximity to the Golgi apparatus. (PMID:27009467)
- Expression of TMEM176A in colorectal cancer cells is regulated by promoter region methylation. Methylation of TMEM176A was associated with tumor metastasis and was an independent prognostic factor for 5-year overall survival. (PMID:28678648)
- Single nucleotide polymorphism in TMEM176A gene is associated with schizophrenia risk loci with potential implications for neurocognitive performance. (PMID:28902459)
- The promoter region of TMEM176A is frequently methylated in human hepatocellular carcinoma (HCC), and the expression of TMEM176A is regulated by promoter region methylation. Methylation of the TMEM176A promoter may serve as a diagnostic and prognostic marker in HCC. TMEM176A suppresses HCC growth by inhibiting the ERK signaling pathway. (PMID:30400968)
- TMEM176A and TMEM176B Are Candidate Regulators of Inhibition of Dendritic Cell Maturation and Function after Chronic Spinal Cord Injury. (PMID:31354034)
- TMEM176A acts as a tumor suppressor gene in pancreatic cancer by inhibiting ERK signaling. (PMID:33593482)
- Methylation of TMEM176A, a key ERK signaling regulator, is a novel synthetic lethality marker of ATM inhibitors in human lung cancer. (PMID:34558311)
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Tmem176a | ENSMUSG00000023367 |
| rattus_norvegicus | Tmem176a | ENSRNOG00000023708 |
Paralogs (1): TMEM176B (ENSG00000106565)
Protein
Protein identifiers
Transmembrane protein 176A — Q96HP8 (reviewed: Q96HP8)
Alternative names: Hepatocellular carcinoma-associated antigen 112
All UniProt accessions (4): Q96HP8, A0A090N8H6, C9JJ63, H7C4P5
UniProt curated annotations — full annotation on UniProt →
Subunit / interactions. Interacts with MCOLN2.
Subcellular location. Membrane.
Similarity. Belongs to the TMEM176 family.
RefSeq proteins (1): NP_060957* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR007237 | CD20-like_TM | Domain |
| IPR009281 | TMEM176A/TMEM176B | Family |
Pfam: PF04103
UniProt features (9 total): transmembrane region 4, sequence variant 3, chain 1, modified residue 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q96HP8-F1 | 73.91 | 0.19 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (1): 38
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 212 (showing top):
GSE37336_LY6C_POS_VS_NEG_NAIVE_CD4_TCELL_DN, GOBP_NEGATIVE_REGULATION_OF_CELL_DEVELOPMENT, GOBP_DENDRITIC_CELL_DIFFERENTIATION, GOBP_REGULATION_OF_DENDRITIC_CELL_DIFFERENTIATION, GNF2_GSTM1, GNF2_HPN, GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_DN, FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_DN, TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP, GOBP_REGULATION_OF_LEUKOCYTE_DIFFERENTIATION, PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP, GOBP_REGULATION_OF_HEMOPOIESIS, GOBP_NEGATIVE_REGULATION_OF_MULTICELLULAR_ORGANISMAL_PROCESS, CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_UP, GOBP_NEGATIVE_REGULATION_OF_HEMOPOIESIS
GO Biological Process (1): negative regulation of dendritic cell differentiation (GO:2001199)
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (1): membrane (GO:0016020)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| dendritic cell differentiation | 1 |
| negative regulation of leukocyte differentiation | 1 |
| regulation of dendritic cell differentiation | 1 |
| binding | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
724 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| TMEM176A | MS4A18 | Q3C1V0 | 600 |
| TMEM176A | MS4A5 | Q9H3V2 | 597 |
| TMEM176A | MS4A15 | Q8N5U1 | 568 |
| TMEM176A | MS4A6A | Q9H2W1 | 534 |
| TMEM176A | TMEM98 | Q9Y2Y6 | 496 |
| TMEM176A | MS4A12 | Q9NXJ0 | 487 |
| TMEM176A | MS4A8 | Q9BY19 | 466 |
| TMEM176A | CPXM1 | Q96SM3 | 438 |
| TMEM176A | MS4A4A | Q96JQ5 | 425 |
| TMEM176A | KLF9 | Q13886 | 418 |
| TMEM176A | GDAP1L1 | Q96MZ0 | 418 |
| TMEM176A | TMEM47 | Q9BQJ4 | 412 |
| TMEM176A | TMEM252 | Q8N6L7 | 391 |
| TMEM176A | PLTP | P55058 | 387 |
| TMEM176A | GDAP1 | Q8TB36 | 381 |
IntAct
46 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| TMEM176B | TMEM176A | psi-mi:“MI:0915”(physical association) | 0.560 |
| TMEM176A | SCD5 | psi-mi:“MI:0915”(physical association) | 0.560 |
| RETREG3 | TMEM176A | psi-mi:“MI:0915”(physical association) | 0.560 |
| SGPL1 | TMEM176A | psi-mi:“MI:0915”(physical association) | 0.560 |
| CD79A | TMEM176A | psi-mi:“MI:0915”(physical association) | 0.560 |
| KCNK5 | TMEM176A | psi-mi:“MI:0915”(physical association) | 0.560 |
| TMEM176A | TMX2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TMEM176A | MTIF3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TMEM176A | TIMMDC1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| GOLM1 | TMEM176A | psi-mi:“MI:0915”(physical association) | 0.560 |
| MFSD14B | TMEM176A | psi-mi:“MI:0915”(physical association) | 0.560 |
| TMEM176A | CERS4 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TMEM176A | LITAF | psi-mi:“MI:0915”(physical association) | 0.560 |
| TMEM176A | HIVEP1 | psi-mi:“MI:0915”(physical association) | 0.370 |
| TGM2 | TMEM176A | psi-mi:“MI:0915”(physical association) | 0.370 |
| RIDA | TMEM176A | psi-mi:“MI:0915”(physical association) | 0.370 |
| VCP | SHTN1 | psi-mi:“MI:0914”(association) | 0.350 |
| VCP | FAM171A2 | psi-mi:“MI:0914”(association) | 0.350 |
| TMEM176B | TMEM176A | psi-mi:“MI:0915”(physical association) | 0.000 |
| TMEM176A | SCD5 | psi-mi:“MI:0915”(physical association) | 0.000 |
| TMEM176A | CD79A | psi-mi:“MI:0915”(physical association) | 0.000 |
| TMEM176A | KCNK5 | psi-mi:“MI:0915”(physical association) | 0.000 |
| TMEM176A | TMX2 | psi-mi:“MI:0915”(physical association) | 0.000 |
| TMEM176A | MTIF3 | psi-mi:“MI:0915”(physical association) | 0.000 |
| TMEM176A | MFSD14B | psi-mi:“MI:0915”(physical association) | 0.000 |
| TMEM176A | CERS4 | psi-mi:“MI:0915”(physical association) | 0.000 |
| TMEM176A | RETREG3 | psi-mi:“MI:0915”(physical association) | 0.000 |
| TMEM176A | SGPL1 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (17): CERS4 (Two-hybrid), CD79A (Two-hybrid), TMEM176B (Two-hybrid), TIMMDC1 (Two-hybrid), MTIF3 (Two-hybrid), GOLM1 (Two-hybrid), FAM134C (Two-hybrid), SCD5 (Two-hybrid), HIATL1 (Two-hybrid), KCNK5 (Two-hybrid), SGPL1 (Two-hybrid), TMX2 (Two-hybrid), TMEM176A (Affinity Capture-MS), TMEM176A (Two-hybrid), TMEM176A (Two-hybrid)
ESM2 similar proteins: A4IIU3, A6NML5, D3YWQ9, O75204, P0DP42, P11836, P20490, P56749, Q01362, Q0IIL2, Q2KJ11, Q2YDM3, Q32KQ5, Q3T110, Q3YBM2, Q497B3, Q4G068, Q504G0, Q5EB63, Q5FWC3, Q5HYL7, Q5M962, Q5R8D6, Q5R9K1, Q5RCD5, Q5RFC1, Q6GV28, Q7T392, Q7TQI0, Q7YQI4, Q8BGP5, Q8BHH8, Q8C6V3, Q8K177, Q8NCR9, Q8VHW1, Q8WXS4, Q920C4, Q925D4, Q940P5
Diamond homologs: Q3YBM2, Q4G068, Q5R8D6, Q7YQI4, Q925D4, Q96HP8, Q9DCS1, Q9R1Q6
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
47 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 31 |
| Likely benign | 4 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1348 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 7:150801202:G:GT | donor_gain | 1.0000 |
| 7:150801534:A:AG | acceptor_gain | 1.0000 |
| 7:150801535:G:GG | acceptor_gain | 1.0000 |
| 7:150801535:GACT:G | acceptor_gain | 1.0000 |
| 7:150801828:T:G | donor_gain | 1.0000 |
| 7:150802213:A:AG | acceptor_gain | 1.0000 |
| 7:150802214:G:GG | acceptor_gain | 1.0000 |
| 7:150802323:GTG:G | donor_gain | 1.0000 |
| 7:150802324:TG:T | donor_gain | 1.0000 |
| 7:150802325:GG:G | donor_gain | 1.0000 |
| 7:150802326:G:GG | donor_gain | 1.0000 |
| 7:150802326:GTGA:G | donor_loss | 1.0000 |
| 7:150802327:T:G | donor_loss | 1.0000 |
| 7:150803618:A:AG | acceptor_gain | 1.0000 |
| 7:150803619:G:GG | acceptor_gain | 1.0000 |
| 7:150803829:GAAG:G | donor_gain | 1.0000 |
| 7:150803830:AAG:A | donor_gain | 1.0000 |
| 7:150803831:AG:A | donor_gain | 1.0000 |
| 7:150803831:AGG:A | donor_loss | 1.0000 |
| 7:150803832:GG:G | donor_gain | 1.0000 |
| 7:150803833:G:GG | donor_gain | 1.0000 |
| 7:150804470:GGG:G | donor_gain | 1.0000 |
| 7:150804471:GGG:G | donor_gain | 1.0000 |
| 7:150804825:A:AG | acceptor_gain | 1.0000 |
| 7:150804826:G:GA | acceptor_gain | 1.0000 |
| 7:150804826:GAAAA:G | acceptor_gain | 1.0000 |
| 7:150800961:G:GT | donor_gain | 0.9900 |
| 7:150801531:CATA:C | acceptor_loss | 0.9900 |
| 7:150801533:T:G | acceptor_gain | 0.9900 |
| 7:150801533:TA:T | acceptor_loss | 0.9900 |
AlphaMissense
1504 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 7:150802242:A:C | S68R | 0.984 |
| 7:150802244:T:A | S68R | 0.984 |
| 7:150802244:T:G | S68R | 0.984 |
| 7:150804401:T:A | W199R | 0.963 |
| 7:150804401:T:C | W199R | 0.963 |
| 7:150802233:G:A | G65R | 0.961 |
| 7:150802233:G:C | G65R | 0.961 |
| 7:150802311:T:A | W91R | 0.958 |
| 7:150802311:T:C | W91R | 0.958 |
| 7:150802234:G:A | G65E | 0.949 |
| 7:150802233:G:T | G65W | 0.931 |
| 7:150803806:T:A | C177S | 0.927 |
| 7:150803807:G:C | C177S | 0.927 |
| 7:150802317:G:T | G93W | 0.916 |
| 7:150802254:G:A | G72R | 0.915 |
| 7:150802254:G:C | G72R | 0.915 |
| 7:150802257:G:A | G73R | 0.914 |
| 7:150802257:G:C | G73R | 0.914 |
| 7:150802318:G:A | G93E | 0.914 |
| 7:150803424:T:C | F104L | 0.911 |
| 7:150803426:C:A | F104L | 0.911 |
| 7:150803426:C:G | F104L | 0.911 |
| 7:150804395:G:C | G197R | 0.911 |
| 7:150803412:G:A | G100R | 0.906 |
| 7:150803412:G:C | G100R | 0.906 |
| 7:150802255:G:A | G72E | 0.904 |
| 7:150803806:T:C | C177R | 0.904 |
| 7:150802317:G:A | G93R | 0.902 |
| 7:150802317:G:C | G93R | 0.902 |
| 7:150803413:G:A | G100E | 0.902 |
dbSNP variants (sampled 300 via entrez): RS1000385570 (7:150801115 G>A,C,T), RS1000693691 (7:150800282 G>A,T), RS1000853523 (7:150801986 A>G,T), RS1001873796 (7:150802273 G>A,C,T), RS1002186835 (7:150804648 A>G), RS1002520192 (7:150803125 G>A,C), RS1002554835 (7:150802719 T>C), RS1002871316 (7:150799915 G>A), RS1002984757 (7:150805450 T>C), RS1004260764 (7:150804753 T>A), RS1004499859 (7:150798982 T>C), RS1004633590 (7:150805069 T>C), RS1004989859 (7:150802339 G>C), RS1006273896 (7:150801716 G>A,T), RS1006446041 (7:150801226 G>A,T)
Disease associations
OMIM: gene MIM:610334 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
9 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST000817_88 | Height | 3.000000e-13 |
| GCST001956_82 | Height | 4.000000e-09 |
| GCST002223_57 | HDL cholesterol | 2.000000e-08 |
| GCST002955_6 | Forced expiratory volume in 1 second (occupational environmental exposures interaction) | 4.000000e-07 |
| GCST004232_74 | HDL cholesterol levels | 2.000000e-08 |
| GCST005648_3 | Serum metabolite concentrations in chronic kidney disease | 2.000000e-12 |
| GCST009391_185 | Metabolite levels | 5.000000e-09 |
| GCST90011900_194 | Serum alkaline phosphatase levels | 3.000000e-10 |
| GCST90020029_1137 | Waist circumference adjusted for body mass index | 1.000000e-08 |
EFO canonical traits (6, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004612 | high density lipoprotein cholesterol measurement |
| EFO:0004314 | forced expiratory volume |
| EFO:0006994 | response to gases and fumes exposure |
| EFO:0010482 | gamma-aminoisobutyric acid measurement |
| EFO:0004533 | alkaline phosphatase measurement |
| EFO:0007789 | BMI-adjusted waist circumference |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
25 total (human), top 25 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Tobacco Smoke Pollution | decreases expression, decreases methylation | 3 |
| Aflatoxin B1 | affects expression, decreases expression, decreases methylation | 3 |
| Benzo(a)pyrene | decreases expression | 2 |
| Cyclosporine | decreases expression | 2 |
| methyleugenol | decreases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| terbufos | increases methylation | 1 |
| beta-lapachone | decreases expression | 1 |
| sodium arsenite | decreases expression | 1 |
| S-(1,2-dichlorovinyl)cysteine | affects response to substance, increases expression, decreases expression | 1 |
| perfluoro-n-nonanoic acid | decreases expression | 1 |
| Acetaminophen | decreases expression | 1 |
| Atrazine | increases expression | 1 |
| Calcitriol | decreases expression | 1 |
| Fonofos | increases methylation | 1 |
| Lipopolysaccharides | affects response to substance, increases expression | 1 |
| Nickel | increases expression | 1 |
| Parathion | increases methylation | 1 |
| Rotenone | increases expression | 1 |
| Triclosan | increases expression | 1 |
| Valproic Acid | decreases expression, decreases methylation | 1 |
| Vitamin E | increases expression | 1 |
| 1-Methyl-4-phenylpyridinium | increases expression | 1 |
| Antirheumatic Agents | decreases expression | 1 |
| Okadaic Acid | decreases expression | 1 |
Cellosaurus cell lines
1 cell lines: 1 cancer cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_E0RC | Ubigene HeLa TMEM176A KO | Cancer cell line | Female |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.